Erratum: What is the oncologic risk of stem cell treatment for heart disease? (Circulation Research (2011) 108 (1300-1303))

K. W. Hatzistergos, A. Blum, T. A. Ince, J. M. Grichnik, J. M. Hare

Research output: Contribution to journal › Comment/debate

@article{e3fa84cdc44b425fb13dc6c2365ea0d9,

title = "Erratum: What is the oncologic risk of stem cell treatment for heart disease? (Circulation Research (2011) 108 (1300-1303))",

author = "Hatzistergos, {K. W.} and A. Blum and Ince, {T. A.} and Grichnik, {J. M.} and Hare, {J. M.}",

year = "2011",

month = sep

day = "2",

doi = "10.1161/RES.0b013e3182325df3",

language = "English (US)",

volume = "109",

pages = "e51",

journal = "Circulation Research",

issn = "0009-7330",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Erratum

T2 - What is the oncologic risk of stem cell treatment for heart disease? (Circulation Research (2011) 108 (1300-1303))

AU - Hatzistergos, K. W.

AU - Blum, A.

AU - Ince, T. A.

AU - Grichnik, J. M.

AU - Hare, J. M.

PY - 2011/9/2

Y1 - 2011/9/2

UR - http://www.scopus.com/inward/record.url?scp=80052600464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052600464&partnerID=8YFLogxK

U2 - 10.1161/RES.0b013e3182325df3

DO - 10.1161/RES.0b013e3182325df3

M3 - Comment/debate

AN - SCOPUS:80052600464

VL - 109

SP - e51

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 6

ER -